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The centromedian (CM) nucleus is an intralaminar thalamic nucleus that is considered as
a potentially effective target of deep brain stimulation (DBS) and ablative surgeries for the
treatment of multiple neurological and psychiatric disorders. However, the structure of
CM is invisible on the standard T1- and T2-weighted (T1w and T2w) magnetic resonance
images, which hamper it as a direct DBS target for clinical applications. The purpose of
the current study is to demonstrate the use of quantitative susceptibility mapping (QSM)
technique to image the CM within the thalamic region. Twelve patients with Parkinson’s
disease, dystonia, or schizophrenia were included in this study. A 3D multi-echo gradient
recalled echo (GRE) sequence was acquired together with T1w and T2w images on a
3-T MR scanner. The QSM image was reconstructed from the GRE phase data. Direct
visual inspection of the CM was made on T1w, T2w, and QSM images. Furthermore,
the contrast-to-noise ratios (CNRs) of the CM to the adjacent posterior part of thalamus
on T1w, T2w, and QSM images were compared using the one-way analysis of variance
(ANOVA) test. QSM dramatically improved the visualization of the CM nucleus. Clear
delineation of CM compared to the surroundings was observed on QSM but not on T1w
and T2w images. Statistical analysis showed that the CNR on QSM was significantly
higher than those on T1w and T2w images. Taken together, our results indicate that
QSM is a promising technique for improving the visualization of CM as a direct targeting
for DBS surgery.
Keywords: deep brain stimulation, direct targeting, gradient recalled echo, quantitative susceptibility mapping,
centromedian nucleus
Abbreviations: CM, centromedian nucleus; CNR, contrast-to-noise ratio; DBS, deep brain stimulation; GRE, gradient
recalled echo; MRI, magnetic resonance imaging; QSM, quantitative susceptibility mapping; T1w, T1-weighted; T2w,
T2-weighted.
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INTRODUCTION
The centromedian nucleus (CM) or centromedian–parafasicular
nucleus complex, located in the caudal intralaminar thalamic
nuclei, has been reported to be a potentially effective target
for deep brain stimulation (DBS) or ablative surgeries for the
treatment of various neurological and psychiatric diseases,
e.g., Parkinson’s disease, Tourette syndrome, generalized
epilepsy, and intractable neuropathic pain (Ilyas et al., 2019).
However, the surgeries targeting CM still relied on the indirect
targetingmethod by registering a normalized atlas to the patient’s
magnetic resonance imaging (MRI) data and then the CM
coordinates are used for target localization (Krauss et al., 2002;
Kim et al., 2017; Sharma et al., 2017). This indirect targeting
method may lead to suboptimal targeting since significant
variations exist in brain structures between patients, and this
variation causes unpredictable registration errors (Kennedy
et al., 1998) and may sub-optimize treatment effect and increase
the rate of surgical complications and adverse side effects
(Chan et al., 2009).
Direct targeting can improve the targeting accuracy in certain
aspects as revealed by some studies (Tonge et al., 2016; Fenoy
and Schiess, 2018). Direct targeting requires that the anatomical
locations can be visible on certain image contrast. However,
direct visualization of the CM nucleus using the standard T1w
and T2wMRI sequences is challenging. On one hand, the volume
of the CM is small (smaller than 10 mm in most dimensions;
Ilyas et al., 2019). On the other hand, the contrast between
the CM nucleus and its surrounding thalamic structures is
pretty low. The absence of an imaging technique for direct
visualization of CM hampers the targeting accuracy of CM for
DBS surgery.
Some researchers have made considerable efforts to improve
the individualized depiction of thalamic substructures. Lemaire
et al. (2010) reported that high-resolution T1w images could be
used to image the substructures of the thalamus, which were very
comparable to myelin-stained histologic sections. However, the
scan time for the protocol was approximately 14 h, which is not
suitable for routine clinical scans. Kanowski et al. (2010) showed
that the CM is identifiable in a reasonable measurement time
of 13–26 min with two-dimensional high-resolution proton-
attenuation-weighted images at 3 T. However, only a few slices
in axial plane covering the localized areas were acquired, which
still challenges targeting localization when using the surgical
planning software involving the 3D image registration procedure.
Bender et al. (2011) demonstrated that the CM could be roughly
identified by optimized 3DMPRAGE protocol, which would take
about 20 min to be acquired; however, clear discrimination of all
thalamic substructures were not achievable. If anatomic imaging-
based targeting methods can be further improved, the accuracy
and efficiency of target selection for DBS or ablative surgeries
may further increase.
Quantitative susceptibility mapping (QSM) reconstructed
from the MRI phase images of the 3D gradient recalled echo
(GRE) sequences could improve tissue contrast compared to T2w
images. QSM employed deconvolution of GRE phase images
and removed the non-local susceptibility effects, depicting more
accurate structural delineation (Liu et al., 2015). QSM has been
clinically used to assess important tissue functions and disease
(Wang et al., 2017), and recently it has been demonstrated
for improving the depiction of DBS target structures with
iron-rich nucleus (paramagnetic), e.g., the subthalamic nucleus
(Liu et al., 2013; Alkemade et al., 2017) and the globus pallidus
internus (Wei et al., 2019), with the surrounding white matters
(diamagnetic). The thalamus contains different subregions that
are known to have various iron deposits and different degrees
of myelinated white matters (Morris et al., 1992; Zhang et al.,
2018), which indicates that QSM, by using the susceptibility
differences existing between substructures, may be a proper
imaging technique to identify CM.
The aim of this study is to examine whether QSM could
delineate the CM nucleus from its adjacent thalamic structures
and thus generate a direct visualization of the CM.
MATERIALS AND METHODS
Human Subjects
Twelve patients (six males and six females, mean age
41.8 ± 21.2 years old) with Parkinson’s disease (n = 5, mean
age 61.0 ± 16.6), dystonia (n = 4, mean age 32.8 ± 8.6), or
schizophrenia (n = 3, mean age 21.7 ± 10.3) were included as
convenient samples in this study. Demographic information
collection and neuroradiological investigation were performed
by specialized movement disorder neurologists or psychiatrists.
The study was approved by the ethics committee of Ruijin
Hospital, School of Medicine, Shanghai Jiao Tong University.
All subjects provided written consent in accordance with the
Declaration of Helsinki.
Data Acquisition
Imaging was performed on a 3.0-T MR scanner equipped with
a 24-channel head coil. Each subject lay supine with their head
snugly fixed with foam pads. The subject was asked to keep still as
long as possible. 3D T1w and axial T2w images were acquired. A
multi-echo GRE sequence was also performed. Detailed imaging
parameters, including the time of repetition, time of echo, field
of view, voxel size, and total duration of scanning for the three
imaging modalities, are summarized in Table 1.
Image Processing
QSM images were reconstructed from GRE phase data. The
details of QSM processing has been documented in the previous
articles (Wei et al., 2015, 2017). In brief, three major steps
were taken for the reconstruction of the QSM image. First,
the phase images of GRE were unwrapped using a Laplacian-
based phase unwrapping. Afterward, the magnitude images were
used to extract the brain tissue using the FMRIB Software
Library Brain Extraction Tool1. Then, the background phases
were removed using the V_SHARP method to obtain the local
tissue phase images (Li et al., 2015). Finally, susceptibility maps
were generated after dipole inversion using streaking artifact
reduction for QSMmethod (STAR-QSM; Wei et al., 2015).
1https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/BET
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TABLE 1 | Imaging parameters.
Parameter 3D T1w 2D T2w 3D GRE
Imaging plane Axial Axial Axial
Field of vision (mm) 240 × 240 240 × 240 240 × 240
Matrix 320 × 320 320 × 320 320 × 320
Resolution (mm) 0.75 × 0.75 × 1.5 0.75 × 0.75 × 1.5 0.75 × 0.75 × 1.5
Time of repetition (ms) 7.04 3,000/4,000 32.80
Time of echo (ms) 3.47 128.60/106.03 11.00
Scan time (s) 172 346 528
Image Inspection and Data Analysis
Firstly, we compared the QSM images to a schematic drawing
referenced from the overlay of Schaltenbrand and Wahren
histologic atlas (Schaltenbrand et al., 1977) to confirm whether
the CM can be visible on the QSM image. To calculate the
contrast-to-noise ratios (CNRs), QSM and T2w images were
firstly registered to the T1w image. Then, the regions of CM and
the adjacent posterior thalamic tissues were manually defined
as masks on the QSM image (Supplementary Figure S1).
Afterward, the masks of CM and posterior thalamus were
applied to the T1w and T2w images. The CNRs of the CM
nucleus referenced to the posterior thalamus were measured:
CNR = |SCM−SpTH|/σ, where SCM and SpTH, respectively,
represent the mean signal intensities of the CM nucleus and
posterior part of thalamus. σ represents noise measurement
calculated as the standard deviation of the signal intensities in
the posterior part of thalamus. The volumes of the CM nucleus
were also calculated on QSM images, by multiplying the number
of CM voxels and the voxel size.
Statistical Analysis
A one-way analysis of variance (ANOVA) was used to compare
the difference in CNRs among the three MR image modalities
(IBM SPSS Statistics, version 22). If the one-way ANOVA
gave a significant result, independent two-sample t-tests were
further used as the post hoc tests to reveal the CNR differences
between each two modalities (T1w vs. T2w, T1w vs. QSM,
and T2w vs. QSM). Two-way repeated-measure ANOVAs were
also performed to examine the significance of interaction
between image modality (T1w, T2w, and QSM) and patient
type (Parkinson’s disease, dystonia, and schizophrenia), and
the significance of interaction between CM volume (left CM
and right CM volumes) and patient type. The threshold of
significance was set at p< 0.05.
RESULTS
Figure 1A shows a schematic drawing of thalamus that
is referenced to the Schaltenbrand and Wahren atlas
(Schaltenbrand et al., 1977). The diamagnetic CM is surrounded
by the relatively paramagnetic medial, lateral, and posterior parts
of the thalamus (Figure 1A). Figures 1B,D show the QSM image
of one representative patient. As shown, the QSM image provides
a clear visualization on the anatomical structure of the CM (as
indicated by an orange arrow) in a patient with Parkinson’s
disease. The anatomical boundaries of the medial, lateral, and
posterior parts of the thalamus are also visible owing to different
magnetic susceptibility values, as delineated in Figure 1C.
Figure 2 compares the contrast of CM on T1w, T2w, and
QSM images at one representative section of a representative
patient. The location of CM nucleus is difficult to be identified
on the T1w or T2w images. However, QSM image clearly
shows the substructures of the thalamus, for example,
medial, lateral, and posterior parts of the thalamus. The
CM nucleus is delineable from its surroundings on the
QSM image. Clear delineation of CM and the surrounding
tissues is attributed to the susceptibility difference existed
between iron-rich nucleus and the adjacent myelinated
white fiber axons. The QSM image exhibits a diamagnetic
susceptibility within the CM and a relatively paramagnetic
susceptibility of its surrounding thalamic tissues. The
T1w, T2w, and QSM images at one representative section
containing CM nucleus on each patient are presented in the
Supplementary Figure S2.
FIGURE 1 | The visualization of CM within the thalamus on quantitative
susceptibility mapping (QSM) image. (A) A schematic drawing of the CM and
its surrounding thalamic structures, referenced to the overlay of the
Schaltenbrand and Wahren atlas (Schaltenbrand et al., 1977). (B) An axial
view of a slice of QSM image with thalamic substructures on a representative
patient. (C) Enlarged view of thalamic substructures with the anatomical
boundaries of CM and its surrounding thalamic parts (medial, lateral, and
posterior) delineated. (D) Enlarged view of thalamic substructures. The
anatomical location of CM nucleus is pointed by an orange arrow.
Abbreviations: CM, centromedian nucleus. L, lateral part of thalamus; M,
medial part of thalamus; P, posterior part of thalamus.
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FIGURE 2 | Comparison of the visualization of the CM nucleus on T1w, T2w, and QSM images. Axial slice views (upper row) and enlarged views of the thalamus
(lower row) on T1w, T2w, and QSM images at one representative section on a representative patient. Abbreviations: CM, centromedian nucleus; QSM, quantitative
susceptibility mapping.
The CNRs of the CMnucleus to the posterior part of thalamus
are 0.37 ± 0.35, 0.67 ± 0.43, and 3.43 ± 0.49, respectively, on
T1w, T2w, and QSM images (Figure 3). The ANOVA reveals
significant differences among T1w, T2w, and QSM images in
terms of the CNR, F(2) = 177.14, p < 0.001 (Figure 3). Post
hoc tests (independent two-sample t-tests) indicate significant
different CNRs between QSM and T1w (t(11) = 16.66, p< 0.001),
and between QSM and T2w (t(11) = 17.44, p < 0.001). The
mean CNRs for each type of patients are illustrated in the
Supplementary Table S1, in which increased CNRs on QSM
images are indicated in each of the three patient types. The mean
volumes of the left and right CM nuclei are 160.95 ± 29.98 mm3
and 169.73 ± 50.34 mm3, respectively, as detected on the
QSM images. No significant main effects of patient type on
CNR value or CM volume, or interactions between patient
type and CNR value, or between patient type and CM volume
were found in our sample (ps > 0.142, Supplementary
Tables S1, S2).
DISCUSSION
The results demonstrate that with the QSM technique,
the CM can be clearly delineated from the surrounding
subthalamic nuclei. Compared with commonly used T1w and
T2w images for DBS planning, QSM significantly improved
the CNR of CM nucleus compared to its surrounding
thalamic structures, suggesting that a QSM-based image is
more suitable to target the patient-specific CM in DBS
surgery directly.
FIGURE 3 | The CNRs of the CM to the posterior part of thalamus on the
T1w, T2w, and QSM images. The dots represent the individual values of the
Parkinson’s disease patients (square dots), the dystonia patients (circular
dots), and the schizophrenia patients (triangle dots). ∗∗∗ Indicates p < 0.001.
Abbreviations: CM, centromedian nucleus; pTH, posterior thalamus; QSM,
quantitative susceptibility mapping.
Aside from the surgical targets routinely used in clinical
treatment (e.g., subthalamic nucleus, nucleus accumbens), there
are some other targets with potential effectiveness in treating
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neurological and psychiatric diseases. The CM nucleus or
centromedian–parafasicular nucleus complex, situated within
the intralaminar nuclei of the thalamus, has abundant fiber
connections with other thalamic nuclei, basal ganglia, and
cerebral cortex (Ilyas et al., 2019). In several studies, the CM
nucleus has been suggested as a potentially effective DBS
target for the treatment of Parkinson’s disease (Caparros-
Lefebvre et al., 1999; Mazzone et al., 2006; Peppe et al.,
2008; Stefani et al., 2009) and Tourette syndrome (Houeto
et al., 2005; Savica et al., 2012; Testini et al., 2016; Marano
et al., 2019). The clinical surgeries targeting at CM also
show treatment effect for the generalized epilepsy (Fisher
et al., 1992; Velasco et al., 2007; Valentín et al., 2013; Li
and Cook, 2018) and intractable neuropathic pain (Young
et al., 1995; Hollingworth et al., 2017) by means of DBS
or thalamotomy. The DBS surgery targeting the CM nucleus
currently uses indirect ways in which a two-dimensional
stereotactic atlas of the thalamus is superimposed on a CT or
MRI scan relative to coarse anatomical landmarks including
anterior and posterior commissures (Stefani et al., 2009; Son
et al., 2016; Testini et al., 2016). The indirect method of
targeting the CM nucleus is due to the small volume of
the CM, measuring smaller than 10 mm in most dimensions
(Ilyas et al., 2019), and low image contrast between the CM
nucleus and its surrounding thalamic structures on conventional
MRI images. The challenge of precisely locating the nucleus
would limit the clinical application and the efficacy of CM-
DBS. Inter-patient variability may affect the accuracy of the
placement DBS electrodes, and may sub-optimize treatment
effect and increase the rate of surgical complications and
adverse side effects (Chan et al., 2009). Direct imaging CM
can be of great help for direct targeting of this intralaminar
thalamic nucleus.
Recently developed QSM image reconstructed from the
GRE-sequence image is an effective technique that takes
advantage of differentiated iron concentration in different
subcortical microstructures to identify their locations (Deistung
et al., 2017). Thalamic nuclei have sufficient iron concentration
and different nuclei are with different levels of iron deposits
(Drayer et al., 1986; Morris et al., 1992). Thus, QSM can delineate
one nucleus from its adjacent myelinated white matter axons,
such as for imaging the CM in this study. The delineation
of CM is attributed to the susceptibility difference existed in
iron concentration compared to the adjacent myelin sheath
fibers. Although CM nucleus is also visible on high-resolution
T1w images, 2-D proton-attenuation-weighted images, or images
acquired by optimized 3D MPRAGE protocol (Kanowski et al.,
2010; Lemaire et al., 2010; Bender et al., 2011), those images
usually would take at least 20 min (or even hours) to be acquired.
GRE image of the whole brain can be acquired within less than
10 min, which is more realistic for routine clinical scans for
DBS planning.
Based on our finding that QSM could provide direct
visualization on CM nucleus, together with the recent findings
that QSM could also provide superior anatomical delineation in
subthalamic nucleus (Liu et al., 2013; Alkemade et al., 2017) and
globus pallidus internus (Wei et al., 2019), the implementation
of QSM imaging in clinical settings for relevant diseases
should be given consideration by radiologists, neurosurgeons,
MR manufacturers, and engineers. On the other hand, the
QSM technique has plenty of room to improve on for
clinical applications, including shortening acquisition time and
reducing streaking artifacts to further improve the image quality
(Wang et al., 2017).
The signal intensity on a QSM image depends on the tissue
magnetic susceptibility (Wang and Liu, 2015). Due to the rich
abundancy of iron in the blood, the blood vessel on a QSM
image has a much higher intensity than gray matter, white
matter, or cerebrospinal fluid (Haacke et al., 2015). The visual
identification of the CM nucleus in the present sample is
unaffected by the blood vessels nearby. Furthermore, strong
QSM signal can be observed in the structures with bleeding
or vascular dysmorphia (Liu et al., 2012, 2015; Chen et al.,
2014). Although not being observed in the individuals of our
sample, the delineation of the thalamic structures, including
the CM nucleus, could be blurred in individuals with micro-
bleeding or vascular dysmorphia at or around the regions
of interest.
There are some limitations in the current study. The 3D
GRE sequences is quite sensitive to patients’ motion during
the scan, and thus the application in patients with obvious
tremor might be limited. The next limitation is that the scanning
process for whole-brain QSM takes nearly 5–10 min. Although
it is faster than the other methods that can also demonstrate
the CM nucleus (Kanowski et al., 2010; Lemaire et al., 2010;
Bender et al., 2011), more rapid QSM techniques are yet to
be invented for DBS targeting in clinical application (Wei
et al., 2019). Another limitation is that the segmentations
were done manually in this study. In future studies, the QSM
images could be normalized to MNI space and segmented
based on available subcortical 3D atlases, e.g., using Lead-DBS
toolbox2. Finally, the sample size of the present study is
relatively small. However, even with small sample size, the
superiority of QSM for depicting CM nucleus can still be
observed. The negative results of CNR values and CM volumes
between different types of patients may be attributed to the
limited sample size. Future studies with large sample sizes
are needed to reveal the profiles of CNR values and CM
volumes in different types of patients, particularly in the patients
where DBS has shown potential effectiveness (e.g., Parkinson’s
disease, Tourette syndrome, generalized epilepsy, and intractable
neuropathic pain).
CONCLUSION
In summary, we have demonstrated that the QSM images
provide a significantly clearer visualization of the CM nucleus
than T1w and T2w images, suggesting that a QSM image
is likely more suitable to aid directly determining patient-
specific CM coordinates in the DBS and ablative surgeries.
Future studies are highly needed to evaluate the QSM imaging
CM nucleus on a large sample size, particularly in the
2www.lead-dbs.org
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types of patients who might potentially benefit from DBS
treatment, and confirm whether QSM technique can improve
DBS targeting accuracy or effectiveness compared with indirect
targeting methods.
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